HOME BANCSHARES ($HOMB) posted quarterly earnings results on Wednesday, October 15th. The company reported earnings of $0.61 per share, beating estimates of $0.61 by $0.00. The company also reported revenue of $277,670,000, beating estimates of $275,225,284 by $2,444,716.
You can see Quiver Quantitative's $HOMB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HOME BANCSHARES Insider Trading Activity
HOME BANCSHARES insiders have traded $HOMB stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $HOMB stock by insiders over the last 6 months:
- JOHN W ALLISON (Chairman & CEO) sold 110,000 shares for an estimated $3,302,200
- JOHN STEPHEN TIPTON (Centennial Bank CEO) sold 24,159 shares for an estimated $664,855
- KEVIN HESTER (President and CLO) has made 0 purchases and 2 sales selling 13,473 shares for an estimated $392,872.
- JENNIFER C. FLOYD (Chief Accounting Officer) sold 2,500 shares for an estimated $68,625
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HOME BANCSHARES Hedge Fund Activity
We have seen 164 institutional investors add shares of HOME BANCSHARES stock to their portfolio, and 162 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BARCLAYS PLC added 700,432 shares (+200.4%) to their portfolio in Q2 2025, for an estimated $19,934,294
- AMERICAN CENTURY COMPANIES INC added 626,655 shares (+14.7%) to their portfolio in Q2 2025, for an estimated $17,834,601
- CLEARBRIDGE INVESTMENTS, LLC removed 616,529 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $17,546,415
- SEI INVESTMENTS CO removed 540,874 shares (-62.0%) from their portfolio in Q2 2025, for an estimated $15,393,274
- STATE STREET CORP removed 465,012 shares (-5.2%) from their portfolio in Q2 2025, for an estimated $13,234,241
- CUBIST SYSTEMATIC STRATEGIES, LLC added 454,354 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,930,914
- DIMENSIONAL FUND ADVISORS LP removed 417,052 shares (-6.6%) from their portfolio in Q2 2025, for an estimated $11,869,299
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HOME BANCSHARES Congressional Stock Trading
Members of Congress have traded $HOMB stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HOMB stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HOME BANCSHARES Analyst Ratings
Wall Street analysts have issued reports on $HOMB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 07/18/2025
- Stephens & Co. issued a "Overweight" rating on 04/21/2025
To track analyst ratings and price targets for HOME BANCSHARES, check out Quiver Quantitative's $HOMB forecast page.
HOME BANCSHARES Price Targets
Multiple analysts have issued price targets for $HOMB recently. We have seen 5 analysts offer price targets for $HOMB in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Dave Rochester from Cantor Fitzgerald set a target price of $32.0 on 09/10/2025
- Christopher Mcgratty from Keefe, Bruyette & Woods set a target price of $32.0 on 07/21/2025
- Stephen Scouten from Piper Sandler set a target price of $35.0 on 07/18/2025
- Karl Shepard from RBC Capital set a target price of $31.0 on 04/21/2025
- Matt Olney from Stephens & Co. set a target price of $33.0 on 04/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.